(Press-News.org) Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.
The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid — structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus’s spike protein and preventing it from attaching to real cells.
Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.
Using advanced lab techniques to measure molecular interactions and simulate virus binding, researchers found that the glycosystem binds to the virus 500 times more strongly than a similar compound containing sulphates but no sugars. It was also effective at very low doses and worked against both the original SARS-CoV-2 strain and the more infectious D614G variant.
Tests on human lung cells showed a 98.6% reduction in infection when the molecule was present. Crucially, the research highlighted that its effectiveness stems not just from its charge, but from its precise sugar structure — giving this glycosystem its powerful infection-blocking capability.
The discovery is the result of collaboration between Swansea University, Freie Universität Berlin, and Charité – Universitätsmedizin Berlin.
As the main corresponding author and research supervisor, Dr Sumati Bhatia, Senior Lecturer in Chemistry at Swansea University, said: “Leading this research, alongside our international partners, has been incredibly rewarding. It opens a new direction for using glycosystems as a therapeutic strategy against SARS-CoV-2 and could lay the foundation for a new class of antiviral therapies to protect those most at risk.”
The team is now preparing for further biological testing in high-containment laboratories to assess the molecule’s effectiveness against multiple virus strains.
This breakthrough could pave the way for antiviral nasal sprays, surface disinfectants, and treatments to protect vulnerable groups, offering a new line of defence against Covid-19 and future pandemics.
Read the full study: “Polysialosides Outperform Sulfated Analogues for Binding with SARS‐CoV‐2.”
END
Lab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon
Swansea University
2025-08-11
ELSE PRESS RELEASES FROM THIS DATE:
Rice’s dean of engineering and computing building new software infrastructure for evolutionary biology
2025-08-11
Rice University computer scientist Luay Nakhleh, who also serves as the dean of the George R. Brown School of Engineering and Computing, has received a $1.9 million grant from the National Science Foundation to build a powerful new software infrastructure that could significantly expand how scientists study evolution. The project, titled PhyNetPy, aims to bring the next generation of evolutionary modeling tools into the hands of researchers around the world by enabling the widespread use of phylogenetic networks — complex, ...
Researchers discover all-new antifungal drug candidate in McMaster’s greenhouse
2025-08-11
A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections.
The new molecules, dubbed coniotins, were isolated from a plant-dwelling fungus called Coniochaeta hoffmannii — the samples of which were collected from the McMaster greenhouse, located on the university’s campus.
Detailed recently in the journal Nature Communications, the discovery responds to a critical need for new antifungal medicines.
“There is a huge, growing clinical need for new drugs that target fungal infections,” says Gerry Wright, a ...
New quality control for ‘wonder material’ graphene oxide is cheapest and fastest yet
2025-08-11
Scientists have created new way to characterise graphene oxide (GO) cheaper and quicker than ever before, helping get the emerging technology out of the lab and into the market.
Researchers at King’s College London have designed an ‘interactional fingerprinting’ method that creates a unique identity of individual samples. By mimicking humans’ sense of taste and smell, the method can create a qualitative snapshot of the material without relying on inaccessible gold-standard measurement machinery manned by teams of specialists.
By promising a faster and cheaper way to quality control graphene oxide, the scientists ...
How organic matter traps water in soil — even in the driest conditions
2025-08-11
From lifelong farmers to backyard gardeners, most plant-lovers know that adding organic matter to a field, vegetable plot or flowerpot increases the soil’s moisture.
Now, for the first time, Northwestern University scientists have uncovered the molecular mechanisms that enable organic matter to boost soil’s ability to retain water — even in desert-like conditions.
Carbohydrates — key components of plants and microbes — act like a molecular glue, using water to form sticky bridges between organic molecules and soil minerals, the team found. These bridges lock in moisture that ...
Cancer center taps UTA expert for survivor health study
2025-08-11
A researcher at The University of Texas at Arlington is helping a leading national cancer center explore how wearable devices could help childhood cancer survivors avoid long-term health complications such as diabetes and heart disease. Yue Liao, assistant professor of kinesiology at UT Arlington, was invited by researchers at City of Hope, a National Cancer Institute-designated comprehensive cancer center, to contribute to a review article published in Cancer. The article examines how survivors of childhood cancer face elevated risks of chronic conditions such as diabetes and how digital health tools could help detect—and possibly prevent—these ...
Big gains in type 1 diabetes glucose-control management in recent years
2025-08-11
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found big increases in the use of continuous glucose monitoring and insulin delivery devices by children and adults with type 1 diabetes over a 15-year period, with corresponding jumps in optimal blood-sugar control.
For their study, the researchers used a large national database of de-identified electronic health records to analyze nearly 200,000 individuals with type 1 diabetes across five three-year periods from 2009 to 2023. The research team tracked individuals’ adoption of continuous ...
Researchers unlock safer RNA therapies for inflammatory diseases
2025-08-11
PHILADELPHIA – Lipid nanoparticles (LNPs) are tiny fat bubbles that are used to deliver medicines, genes, and RNA into cells. However, in some cases LNPs can cause harmful inflammation as a result of the process of RNA delivery. Now, two new solutions can help alleviate inflammation while still getting RNA where it needs to be in the cell. One discovery found that inflammation could be reduced with the addition of a unique biodegradable lipid to the treatment; another solution identified a common drug, called thiodigalactoside (TG), which blocked inflammation when added to the LNP. Today’s Nature Nanotechnology features this research from the Perelman ...
New gene linked to aggressive, treatment-resistant prostate cancer
2025-08-11
“These findings highlight that, in PC, RSPO2 functions as a unique member of the R-spondin family by promoting genes and signaling pathways associated with aggressive PC, and RSPO2 amplifications are associated with poor outcomes in PC patients.”
BUFFALO, NY – August 11, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer.”
In this study, researchers led by first ...
Why oxytocin treatments for social behavior are inconsistent
2025-08-11
Oxytocin promotes social behaviors and helps maintain relationships. But clinical trials in patients with autism show variability in how consistently oxytocin improves these behaviors. Steve Chang, from Yale University, led a study to explore how oxytocin influences brain activity to shape social behavior in rhesus monkeys and why its effects are so variable. This work is featured in JNeurosci’s Central Questions for Social Neuroscience Research Special Collection.
The researchers focused on the basolateral amygdala (BLA) and the anterior cingulate cortex (ACC) because these brain areas process reward and integrate ...
The ISSCR releases targeted update to the guidelines for stem cell research and clinical translation
2025-08-11
The International Society for Stem Cell Research (ISSCR) released an update of its 2021 Guidelines for Stem Cell Research and Clinical Translation today. The targeted update addresses significant advances in the development and application of human stem cell-based embryo models (SCBEMs) and recommendations for research oversight outlined in a white paper from the ISSCR Embryo Models Working Group published in June.
SCBEMs are three-dimensional stem cell-derived structures that replicate key aspects of early embryonic development. ...
LAST 30 PRESS RELEASES:
Calorie labelling linked to 2% average reduction in energy content of menu items
Widely prescribed opioid painkiller tramadol not that effective for easing chronic pain
Exercise snacks may boost cardiorespiratory fitness of physically inactive adults
15,000 women a year with breast cancer could benefit from whole genome sequencing, say researchers
Study highlights risks of Caesarean births to future pregnancies
GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds
Scripps Research scientists unlock new patterns of protein behavior in cell membranes
Panama Canal may face frequent extreme water lows in coming decades
Flash Joule heating lights up lithium extraction from ores
COMBINEDBrain and MUSC announce partnership to establish biorepository for pediatric cerebrospinal fluid and CNS tissue bank
Questionable lead reporting for drinking water virtually vanished after Flint water crisis, study reveals
Assessing overconfidence among national security officials
Bridging two frontiers: Mitochondria & microbiota, Targeting Extracellular Vesicles 2025 to explore game-changing pathways in medicine
New imaging tech promises to help doctors better diagnose and treat skin cancers
Once dominant, US agricultural exports falter amid trade disputes and rising competition
Biochar from invasive weed shields rice from toxic nanoplastics and heavy metals
Rice University announces second cohort of Chevron Energy Graduate Fellows
Soil bacteria and minerals form a natural “battery” that breaks down antibiotics in the dark
Jamestown colonists brought donkeys, not just horses, to North America, old bones reveal
FIU cybersecurity researchers develop midflight defense against drone hijacking
Kennesaw State researcher aims to discover how ideas spread in the digital age
Next-generation perovskite solar cells are closer to commercial use
Sleep patterns linked to variation in health, cognition, lifestyle, and brain organization
University of Oklahoma researcher awarded funding to bridge gap between molecular data and tissue architecture
Nationally-recognized pathologist Paul N. Staats, MD, named Chair of Pathology at University of Maryland School of Medicine
The world’s snow leopards are very similar genetically. That doesn’t bode well for their future
Researchers find key to stopping deadly infection
Leafcutter ants have blind spots, just like truck drivers
Tayac receives funding for community engagement project
Parker receives funding for Elementary Education Program Professional Development School (PDS)
[Press-News.org] Lab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizonSwansea University